Article Details
Retrieved on: 2022-04-11 15:39:15
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Epygen Biotech on Monday said it has received a funding of Rs 24 crore from the Department of Biotechnology to initiate trials for a new COVID ...
Article found on: www.businesstoday.in
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here